Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Histopathology|November 11, 2025
Decision-making in breast pathology reporting: the effect of clinical relevant thresholdsZeynep E Kain, Ximena Baez-Navarro, Sabine C Linn, et al.
Pathology|February 10, 2024
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort studyXimena Baez-Navarro, Mieke R van Bockstal, Agnes Jager, et al.
Virchows Archiv : an International Journal of Pathology|September 16, 2025
HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratoriesZeynep E Kain, Ximena Baez-Navarro, Nils A 't Hart, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide CohortXimena Baez-Navarro, Mieke R van Bockstal, Eleni-Rosalina Andrinopoulou, et al.
Archives of Pathology & Laboratory Medicine|October 29, 2024
A Comparison Between Immunohistochemistry and mRNA Expression to Identify Human Epidermal Growth Factor Receptor 2-Low Breast CancerXimena Baez-Navarro, Mieke R van Bockstal, Angelique van der Made, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 20, 2026
Immunohistochemical Assay Variability and HER2-low Breast Cancer Detection: A Laboratory Comparison in the NetherlandsZeynep E Kain, Emma Schuurman, Ximena Baez-Navarro, et al.
Pathology|April 12, 2025
HER2-low across solid tumours: different incidences and definitionsXimena Baez-Navarro, Floris H Groenendijk, Lindsey Oudijk, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Selecting patients with HER2-low breast cancer: Getting out of the tangleXimena Baez-Navarro, Roberto Salgado, Carsten Denkert, et al.
Histopathology|August 6, 2021
Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpointErik Thunnissen, Noriko Motoi, Yuko Minami, et al.
Breast Cancer Research : BCR|March 12, 2024
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?Ximena Baez-Navarro, Nadine S van den Ende, Anh H Nguyen, et al.
Pageof 2